49.30
price down icon1.18%   -0.59
after-market アフターアワーズ: 49.30
loading
前日終値:
$49.89
開ける:
$49.81
24時間の取引高:
1.37M
Relative Volume:
0.61
時価総額:
$8.06B
収益:
$1.17B
当期純損益:
$150.71M
株価収益率:
52.45
EPS:
0.94
ネットキャッシュフロー:
$245.03M
1週間 パフォーマンス:
-4.51%
1か月 パフォーマンス:
+5.39%
6か月 パフォーマンス:
-32.22%
1年 パフォーマンス:
-33.07%
1日の値動き範囲:
Value
$48.41
$49.97
1週間の範囲:
Value
$48.41
$51.24
52週間の値動き範囲:
Value
$46.01
$83.62

Bio Techne Corp Stock (TECH) Company Profile

Name
名前
Bio Techne Corp
Name
セクター
Healthcare (1170)
Name
電話
(612) 379-8854
Name
住所
614 MCKINLEY PL N E, MINNEAPOLIS, MN
Name
職員
3,100
Name
Twitter
@biotechne
Name
次回の収益日
2024-10-30
Name
最新のSEC提出書
Name
TECH's Discussions on Twitter

TECH を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
TECH
Bio Techne Corp
49.30 8.06B 1.17B 150.71M 245.03M 0.94
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
443.54 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
511.92 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
313.13 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
540.76 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
257.51 28.51B 3.81B -644.79M -669.77M -6.24

Bio Techne Corp Stock (TECH) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-05-30 開始されました Wells Fargo Overweight
2025-04-09 ダウングレード KeyBanc Capital Markets Overweight → Sector Weight
2025-03-18 開始されました Evercore ISI Outperform
2025-02-19 ダウングレード Robert W. Baird Outperform → Neutral
2024-05-22 ダウングレード Citigroup Buy → Neutral
2024-02-08 開始されました Scotiabank Sector Outperform
2024-02-02 ダウングレード Stifel Buy → Hold
2023-12-07 開始されました UBS Buy
2023-08-28 開始されました William Blair Outperform
2023-01-10 アップグレード Wells Fargo Underweight → Equal Weight
2022-12-14 開始されました Deutsche Bank Buy
2022-12-12 アップグレード Citigroup Neutral → Buy
2022-12-07 開始されました RBC Capital Mkts Sector Perform
2022-08-25 開始されました Credit Suisse Outperform
2022-04-25 ダウングレード Wells Fargo Equal Weight → Underweight
2021-09-15 アップグレード KeyBanc Capital Markets Sector Weight → Overweight
2021-03-08 アップグレード Stephens Equal-Weight → Overweight
2021-02-23 アップグレード Stifel Hold → Buy
2021-01-25 繰り返されました The Benchmark Company Buy
2020-11-10 開始されました KeyBanc Capital Markets Sector Weight
2020-09-30 開始されました Atlantic Equities Overweight
2020-07-15 ダウングレード Stephens Overweight → Equal-Weight
2020-05-27 ダウングレード Stifel Buy → Hold
2020-05-14 開始されました The Benchmark Company Buy
2020-01-08 再開されました Stephens Overweight
2020-01-08 開始されました Wells Fargo Equal Weight
2020-01-07 開始されました Citigroup Neutral
2019-11-15 開始されました Stifel Buy
2019-07-02 アップグレード Janney Neutral → Buy
2019-01-14 アップグレード Stephens Equal-Weight → Overweight
2018-10-31 ダウングレード Craig Hallum Buy → Hold
2018-10-17 開始されました Goldman Neutral
2018-06-15 開始されました Argus Buy
2017-07-13 開始されました Wells Fargo Market Perform
2017-02-09 開始されました Citigroup Buy
2017-01-18 開始されました Deutsche Bank Buy
2016-11-10 再開されました Leerink Partners Outperform
2015-01-21 繰り返されました Robert W. Baird Outperform
2013-09-20 アップグレード Robert W. Baird Neutral → Outperform
すべてを表示

Bio Techne Corp (TECH) 最新ニュース

pulisher
Jun 17, 2025

Bio-Techne Corp. stock underperforms Tuesday when compared to competitors - MarketWatch

Jun 17, 2025
pulisher
Jun 12, 2025

How the (TECH) price action is used to our Advantage - news.stocktradersdaily.com

Jun 12, 2025
pulisher
Jun 11, 2025

Bio-Techne Director Cashes Out in Significant Stock Sale - TipRanks

Jun 11, 2025
pulisher
Jun 10, 2025

Bio-Techne at Goldman Sachs Conference: Strategic Growth Amid Challenges - Investing.com

Jun 10, 2025
pulisher
Jun 10, 2025

TECH Q1 Earnings Call: Management Highlights Market Uncertainties and Strategic Mitigation Efforts - Yahoo Finance

Jun 10, 2025
pulisher
Jun 10, 2025

Transcript : Bio-Techne Corporation Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 10 - MarketScreener

Jun 10, 2025
pulisher
Jun 10, 2025

Bio-Techne To Present At Goldman Sachs Global Healthcare Conference; Webcast At 10:40 AM ET - Nasdaq

Jun 10, 2025
pulisher
Jun 10, 2025

ScaleReady Announces a G-Rex® Grant has been awarded to Immuneel Therapeutics - Yahoo Finance

Jun 10, 2025
pulisher
Jun 05, 2025

Bio-Techne (TECH) Maintains 'Buy' Rating with $75 Price Target | TECH Stock News - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Benchmark maintains Buy rating on Bio-Techne stock amid tariff impact By Investing.com - Investing.com South Africa

Jun 05, 2025
pulisher
Jun 05, 2025

Benchmark maintains Buy rating on Bio-Techne stock amid tariff impact - Investing.com India

Jun 05, 2025
pulisher
Jun 05, 2025

Stochastic Optical Reconstruction Miicroscope Market Size, - openPR.com

Jun 05, 2025
pulisher
Jun 05, 2025

Deutsche Bank Adjusts Bio-Techne Price Target to $66 From $70 - marketscreener.com

Jun 05, 2025
pulisher
Jun 04, 2025

Bio-Techne at Jefferies Conference: Strategic Growth Amid Challenges - Investing.com

Jun 04, 2025
pulisher
Jun 04, 2025

Transcript : Bio-Techne Corporation Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 03 - marketscreener.com

Jun 04, 2025
pulisher
Jun 03, 2025

Bio-Techne at William Blair Growth Stock: Strategic Insights and Challenges - Investing.com

Jun 03, 2025
pulisher
Jun 03, 2025

Transcript : Bio-Techne Corporation Presents at 45th Annual William Blair Growth Stock Conference, Jun-03-2025 02 - marketscreener.com

Jun 03, 2025
pulisher
Jun 03, 2025

Spotting Winners: Bio-Techne (NASDAQ:TECH) And Research Tools & Consumables Stocks In Q1 - Yahoo Finance

Jun 03, 2025
pulisher
May 31, 2025

Wells Fargo Begins Coverage of Bio-Techne (TECH) Stock, Gives PT of $59 - Insider Monkey

May 31, 2025
pulisher
May 31, 2025

Wells Fargo starts Bio-Techne with Overweight, $59 target - Investing.com Australia

May 31, 2025
pulisher
May 30, 2025

Bio-Techne stock price target cut to $65 by Argus - Investing.com South Africa

May 30, 2025
pulisher
May 30, 2025

Wells Fargo Initiates Coverage on Bio-Techne (TECH) with Overwei - GuruFocus

May 30, 2025
pulisher
May 30, 2025

Wells Fargo starts Bio-Techne with Overweight, $59 target By Investing.com - Investing.com Canada

May 30, 2025
pulisher
May 30, 2025

Demystifying Bio-Techne: Insights From 7 Analyst Reviews - Benzinga

May 30, 2025
pulisher
May 30, 2025

Argus Adjusts Price Target on Bio-Techne to $65 From $90 - marketscreener.com

May 30, 2025
pulisher
May 30, 2025

Wells Fargo Initiates Bio-Techne at Overweight With $59 Price Target - marketscreener.com

May 30, 2025
pulisher
May 30, 2025

Bio-Techne Corporation (TECH): A Bull Case Theory - Insider Monkey

May 30, 2025
pulisher
May 29, 2025

Bio-Techne Corporation: An Insight Into The Pharmaceutical Market Dynamics & China's Economic & Regulatory Environment! - Smartkarma

May 29, 2025
pulisher
May 29, 2025

Is Bio-Techne Stock The Right Pick For Your Portfolio Now? - Barchart.com

May 29, 2025
pulisher
May 29, 2025

Is Bio-Techne Stock the Right Pick for Your Portfolio Now? - Yahoo Finance

May 29, 2025
pulisher
May 29, 2025

Bio-Techne Sets Triple Conference Appearance: William Blair, Jefferies, and Goldman Sachs in June - Stock Titan

May 29, 2025
pulisher
May 22, 2025

Bio-Techne Corp. stock underperforms Wednesday when compared to competitors - MSN

May 22, 2025
pulisher
May 22, 2025

Cetera Investment Advisers Sells 887 Shares of Bio-Techne Co. (NASDAQ:TECH) - Defense World

May 22, 2025
pulisher
May 22, 2025

Exosomes Market Projected to Reach USD 1,311.03 Million by - GlobeNewswire

May 22, 2025
pulisher
May 21, 2025

Do Wall Street Analysts Like Bio-Techne Stock? - MSN

May 21, 2025
pulisher
May 20, 2025

(TECH) Technical Pivots with Risk Controls - news.stocktradersdaily.com

May 20, 2025
pulisher
May 16, 2025

Bio-Techne (NASDAQ:TECH) Rating Increased to Buy at StockNews.com - Defense World

May 16, 2025
pulisher
May 15, 2025

Ex-Dividend Reminder: Bio-Techne, First Hawaiian and Affiliated Managers Group - Nasdaq

May 15, 2025
pulisher
May 14, 2025

Wednesday Sector Laggards: Healthcare, Materials - Nasdaq

May 14, 2025
pulisher
May 14, 2025

What Makes Bio-Techne Corporation (TECH) a Compelling Addition? - Insider Monkey

May 14, 2025
pulisher
May 14, 2025

ScaleReady awards multiple G-Rex® Grants to leading investigators at the University of Southern California (USC) and the Children's Hospital of Los Angeles (CHLA) - Quantisnow

May 14, 2025

Bio Techne Corp (TECH) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Bio Techne Corp (TECH) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Herr Amy E.
Director
Jun 09 '25
Sale
49.77
1,280
63,705
1,976
$20.68
price down icon 2.27%
$35.40
price up icon 1.55%
$20.39
price down icon 0.83%
$105.42
price up icon 2.67%
$103.01
price down icon 3.30%
biotechnology ONC
$257.51
price up icon 4.22%
大文字化:     |  ボリューム (24 時間):